PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsbacterial pneumonia
MeSH D018410 - bacterial pneumonia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011014:Pneumonia
70 Companies
20 Drugs
$
Success rate
D001424:Bacterial infections
244 Companies
144 Drugs
$
Success rate
D018410: 
Bacterial pneumonia
126 Companies
38 Drugs
$
Success rate
D011018:Pneumococcal pneumonia
1 Company
1 Drug
$
Success rate
D011019:Mycoplasma pneumonia
45 Companies
8 Drugs
$
Success rate
D011022:Rickettsial pneumonia
0 Companies
0 Drugs
Success rate
D011023:Staphylococcal pneumonia
0 Companies
0 Drugs
Success rate
D045729:Mycoplasmal pneumonia of swine
0 Companies
0 Drugs
Success rate
D048089:Enzootic pneumonia of calves
0 Companies
0 Drugs
Success rate
D061387:Chlamydial pneumonia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCeftriaxone Ceftriaxone  2007-03-15   
Levofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2015-05-18   
Moxifloxacin Moxifloxacin  2014-02-18   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2015-12-21   
MylanLevofloxacin Levofloxacin  2011-06-20   
Linezolid Linezolid  2017-12-06   
Moxifloxacin Moxifloxacin  2017-05-05   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2015-08-31   
Johnson & JohnsonDoripenem Doribax  2008-07-25   
Levofloxacin Levaquin  1996-12-20   
Chartwell PharmaceuticalsLevofloxacin Levofloxacin  2012-03-30   
Cefepime Cefepime  2010-12-21   
Linezolid Linezolid  2019-04-25   
Moxifloxacin Moxifloxacin  2017-02-13   
GSKCeftazidime Ceptaz  1990-09-27   
Ceftazidime Pentacef  1995-11-07   
RocheCeftriaxone, Lidocaine Rocephin  1985-03-12 $261.076 M Y2021 
Lupin ResearchCeftriaxone Ceftriaxone  2003-09-30   
Levofloxacin Levofloxacin  2011-06-20   
Moxifloxacin Moxifloxacin  2014-09-04   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
70%
16/23
Phase 3
64%
50/78
Approved: 38Overall Success rate: 45%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cefdinir,
Doxycycline hyclate,
Moxifloxacin
Mylan
Doxycycline hyclate,
Moxifloxacin
Mayne Group
Doxycycline hyclate
Johnson & Johnson
Levofloxacin,
Doripenem,
Caficrestat,
Clavulin,
Clavamox
GSK
Ceftazidime,
Cefuroxime axetil,
Cloxacillin,
Prevenar13,
Prevnar13,
Pcv13,
Pneumovax,
Prevenar
Roche
Ceftriaxone,
Lactams
AbbVie
Avibactam,
Ceftazidime
Harrow
Moxifloxacin
Sanofi
Telithromycin,
Lactams
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use